JY
BVS icon

Jeff Yass’s Bioventus BVS Stock Holding History

Jeff Yass’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Sell
25,400
-13,700
-35% -$131K ﹤0.01% 11567
2026
Q1 		$357K Buy
+39,100
New +$328K ﹤0.01% 10482
2025
Q3 		– Sell
-13,000
Closed -$86.1K – 12473
2025
Q2 		$86.1K Sell
13,000
-20,600
-61% -$146K ﹤0.01% 11870
2025
Q1 		$307K Sell
33,600
-17,900
-35% -$179K ﹤0.01% 10026
2024
Q4 		$541K Sell
51,500
-31,500
-38% -$373K ﹤0.01% 8480
2024
Q3 		$992K Sell
83,000
-17,100
-17% -$148K ﹤0.01% 6794
2024
Q2 		$576K Buy
100,100
+1,500
+2% +$8.23K ﹤0.01% 7924
2024
Q1 		$513K Buy
98,600
+31,500
+47% +$154K ﹤0.01% 8453
2023
Q4 		$354K Sell
67,100
-8,300
-11% -$32.8K ﹤0.01% 9481
2023
Q3 		$249K Buy
75,400
+57,100
+312% +$200K ﹤0.01% 9760
2023
Q2 		$52.9K Buy
18,300
+3,300
+22% +$6.33K ﹤0.01% 11318
2023
Q1 		$16.1K Buy
+15,000
New +$28.7K ﹤0.01% 12100

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's BVS Position: Q2 2026 in Review

Jeff Yass reduced its Bioventus (BVS) stake by 17% in Q2 2026, selling an estimated $33.7K and leaving 17,692 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #12115.

Jeff Yass first reported a position in BVS in Q1 2021 and has held it in 13 quarters since. The position peaked at $1.51M in Q1 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Jeff Yass held 17,692 shares of Bioventus worth $167K as of Q2 2026.
  • Jeff Yass sold 3,525 Bioventus shares in Q2 2026, an estimated $33.7K.
  • Bioventus made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12115 holding.
  • Jeff Yass first reported a position in Bioventus in Q1 2021 and has held it in 13 quarters since.
  • Jeff Yass's Bioventus position peaked at $1.51M in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.